Recurrent Solid Tumor

Oncology·MeSH: Sarcoma, Ewing

9 drugs in development·4 companies·3 clinical trials

Drug Pipeline by Phase

Approved(1)

Drug	Company
mekinist	Novartis AG (NVS)

Phase 2(3)

Drug	Company
Dacarbazine or Temozolomide	PTC THERAPEUTICS, INC. (PTCT)
Temozolomide	PTC THERAPEUTICS, INC. (PTCT)
Temozolomide Oral Product	PTC THERAPEUTICS, INC. (PTCT)

Phase 1(4)

Drug	Company
BP1001-A	BIO-PATH HOLDINGS, INC. (BPTH)
Onivyde	PTC THERAPEUTICS, INC. (PTCT)
Talazoparib	PTC THERAPEUTICS, INC. (PTCT)
xmt-2056	Mersana Therapeutics, Inc. (MRSN)

Unknown(1)

Drug	Company
tafinlar/mekinist	Novartis AG (NVS)

BioSniper tracks 9 drugs in development for Recurrent Solid Tumor across 4 companies.

There are 3 clinical trials targeting Recurrent Solid Tumor tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.